Early-stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra

Neuropathology

Volumn 31, Issue 1, 2011, Pages 77-81

  Sakai, Kenji ^a,b   Yamada, Masahito ^b  

^a Noto General Hospital   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Early stage; Progressive supranuclear palsy; Substantia nigra; Subthalamic nucleus; Tau

Indexed keywords

TAU PROTEIN;

AGED; AKINESIA; ARTICLE; ASTROCYTE; BALANCE DISORDER; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN THIRD VENTRICLE; BRAIN VENTRICLE DILATATION; CASE REPORT; CYTOPATHOLOGY; DEGENERATIVE DISEASE; FEMALE; FRONTAL LOBE; GAIT DISORDER; GAZE PARALYSIS; GLOBUS PALLIDUS; HUMAN; HYPERREFLEXIA; JAPANESE; MORTALITY; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL REFLEX; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TEMPORAL LOBE;

AGED; FATAL OUTCOME; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 78751473817     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2010.01134.x     Document Type: Article

References (12)

1. Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathol 2007; 17: 74-82.
2. Williams DR, Holton JL, Strand C et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-Parkinsonism from Richardson's syndrome. Brain 2007; 130: 1566-1576.
3. Kleinschmidt-DeMasters BK. Early progressive supranuclear palsy: pathology and clinical presentation. Clin Neuropathol 1989; 8: 79-84.
4. Hishikawa N, Hashizume Y, Yoshida M, Niwa J, Tanaka F, Sobue G. Tuft-shaped astrocytes in Lewy body disease. Acta Neuropathol 2005; 109: 373-380.
5. Santpere G, Ferrer I. Delineation of early changes in cases with progressive supranuclear palsy-like pathology. Astrocytes in striatum are primary targets of tau phosphorylation and GFAP oxidation. Brain Pathol 2009; 19: 177-187.
6. Litvan I, Agid Y, Calne D et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1-9.
7. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009; 8: 270-279.
8. Shimoda M, Hosoda Y, Kato S et al. Pallidonigroluysian atrophy: clinicopathological and immunohistochemical studies. Neuropathology 1996; 16: 21-28.
9. Hasegawa K, Ryou M, Kowa H, Yagishita S. A clinicopathologic examination of pallidonigroluysian atrophy. Neuropathology 1997; 17: 134-139.
10. Mori H, Motoi Y, Kobayashi T et al. Tau accumulation in a patient with pallidonigroluysian atrophy. Neurosci Lett 2001; 309: 89-92.
11. Konishi Y, Shirabe T, Katayama S, Funakawa I, Terao A. Autopsy case of pure akinesia showing pallido-nigro-luysian atrophy. Neuropathology 2005; 25: 220-227.
12. Wakabayashi K, Takahashi H. Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 2004; 24: 79-86.